Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy
- 1 March 1992
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 48 (3) , 391-396
- https://doi.org/10.1016/0304-3959(92)90089-t
Abstract
A peripheral mononeuropathy was produced in adult male rats by placing loosely constrictive ligatures around the common sciatic nerve. As reported by others, this procedure reliably results in postoperative behavior indicative of hyperalgesia, allodynia, and potentially, spontaneous pain. In these experiments, thermal hyperalgesia was assessed by measuring foot-withdrawal latencies to radiant heat aimed at the plantar surface of rat hind paws. Behaviors potentially indicative of spontaneous pain were assessed by rating spontaneous hind paw guarding positions. Rats with sciatic nerve ligation were divided into 5 groups (n = 6/group). Three groups received injections (i.p.) of either 10, 20 or 40 mg/kg of cerebral ganglioside mixture, GA. The 4th group was injected with 10 mg/kg of the purified ganglioside GM1, and the 5th group received an equal volume of saline. All injections were given daily for 2 days before surgery, the day of surgery and 9 days after surgery. All animals were behaviorally assessed for 2 days prior to surgery, the day of surgery, as well as 1, 3, 5, 7, and 10 days afterwards. All 5 groups had significantly reduced latencies to hind paw withdrawal on the side ipsilateral to sciatic nerve ligation. However, these hyperalgesic responses were significantly attenuated in rats receiving GA or GM1 pretreatment. These data suggest that this animal model of peripheral neuropathic pain is sensitive to pharmacological manipulations useful for understanding mechanisms of neuropathic pain, including mechanisms related to excitotoxic processes. Such studies could lead to development of clinical approaches to treat this disorder.Keywords
This publication has 27 references indexed in Scilit:
- NMDA receptors - their role in long-term potentiationPublished by Elsevier ,2003
- Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nervesCancer Chemotherapy and Pharmacology, 1990
- Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathyDiabetes, 1989
- Reversibility and prevention of intraspinal peptidergic loss caused by sciatic nerve lesionsJournal of Neuroscience Research, 1989
- GM1 ganglioside protects nucleus basalis from excitotoxin damage: Reduced cortical cholinergic losses and animal mortalityJournal of Neuroscience Research, 1988
- Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.Stroke, 1987
- Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats.Stroke, 1986
- Stimulation of nodal and terminal sprouting of mouse motor nerves by gangliosidesBrain Research, 1984
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977
- The Effects of Mechanical Stimulation on Some Electrical Properties of AxonsThe Journal of general physiology, 1962